NCT07006987

HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women

Clinical Study for HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women of Ages 18-49 Years Considering Laparoscopy

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Chinese University of Hong Kong · Academic / Other
• Sex: Female
• Age: 18 Years – 49 Years
• Healthy volunteers: Accepted

Summary

Endometriosis (EMS) is a common gynecological disease that affects 176 million girls and women globally. EMS affects 5-10% of women and adolescents within the reproductive age range of 15-49 years, and for those facing infertility, this figure may climb up to 50%. EMS can start at the first menstrual period and last until menopause. Shockingly, between 50% and 80% of women grappling with pelvic pain are found to have EMS. The formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body can cause severe pain and lead to infertility.

Conditions

• Endometriosis

Interventions

Type	Name	Description
DEVICE	A non-invasive blood-based (HerResolve)	A non-invasive blood-based test can detect endometriosis as compared to diagnostic laparoscopy

Timeline

• Start date: 2025-10-14
• Primary completion: 2030-05-31
• Completion: 2037-06-01
• First posted: 2025-06-05
• Last updated: 2025-12-03

Locations

1 site across 1 country: China